Bonfire Analytics Closes its First Venture Round to Scale its AI-Driven Sales Intelligence Platform for Healthtech Companies along with Building a Powerful Foundational Dataset Consisting of 300M+ Lives Worth of Medical & Prescription Claims,…
Continue Reading
Are you a healthcare startup in health tech, diagnostics, medtech, or biotech? If so, you should consider applying to the MedCity News startup pitch contest at the MedCity INVEST conference at the Ritz Carlton…
Continue Reading
Dr. Yunpeng Ding, PhD, and Director R&D of Human Nutrition at Aker BioMarine, a biotech innovator and supplier of Superba Krill, the world’s leading krill oil ingredient joins eHealth Radio and the Heart Health…
The NHS should establish a new public-private NHS Data Trust to commercialise and sell access to anonymised NHS medical records to help develop the biotech and AI sectors and new treatments for patients, says…
Continue Reading
Accenture announced it has made a strategic investment, through Accenture Ventures, in QuantHealth, an AI-powered clinical trial design company that simulates clinical trials in the cloud, allowing pharmaceutical and biotech companies to more quickly and…
Continue Reading
8 digital health and life sciences executives share their hot takes and insights from the recent annual JPM Healthcare Conference 2024
Virgil Bretz, co-founder and CEO of MacroHealth
“The annual JP Morgan Healthcare Conference is still…
Continue Reading
I travel to a lot of the major conferences in the healthcare world, but I didn’t make it to this year’s J.P. Morgan Healthcare Conference in San Francisco. Because we all have FOMO from…
Continue Reading
Are you a healthcare startup in health tech, diagnostics, medtech, or biotech? If so, you should consider applying to the MedCity News startup pitch contest at the INVEST conference at the Ritz Carlton in…
Continue Reading
What You Should Know:
– Unnatural Products, Inc. (UNP), a biotech company harnessing the power of AI and chemistry to design the next generation of targeted therapeutics, has secured $32M in Series A funding.
– Led…
Continue Reading
Collaborating for biologic breakthroughs, IBM and Boehringer Ingelheim merge genAI with foundation models. IBM’s cutting-edge AI expedites antibody discovery, targeting diseases like cancer, autoimmune disorders, and infections. Boehringer’s validation of refined antibodies affirms in-silico…
Continue Reading
